How AI is reshaping biopharma decision-making

Artificial intelligence is rapidly transforming the life sciences landscape, but according to Henry Levy, president of life sciences and health care at Clarivate, the real shift is not just about a AI is accelerating discovery, but only when paired with expert insight and trusted data. Hear how leaders are rethinking decision-making in biopharma. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development Fierce 50 Special Report Awards Gala Awards Outsourcing Awards…

Source: FierceBiotech